Helsinki/Finland – Kemira is to build two new plants for coagulants at Bayer sites in Dormagen, Germany as well as in Tarragona, Spain. The investment is € 40 million and the plants are expected to start up in 2012.
Kemira will close an existing coagulant plant in Europoort, the Netherlands. Through a strategic partnership with Bayer MaterialScience, Kemira will buy hydrochloric acid — a by-product of Bayer’s polyurethane production — to produce coagulants for use in water and wastewater treatment. “Coagulants are one of Kemira’s core product lines and ensuring cost efficient supply of raw materials is one of our key strategic objectives,” said Harri Kerminen, President and CEO of Kemira.